Trials / Completed
CompletedNCT03251859
Effectiveness of Lower Maintenance Dose of Ticagrelor Early After Myocardial Infarction (ELECTRA) Pilot Study
A Randomized, Open-label, Pharmacodynamic and Pharmacokinetic Trial Assessing the Effect of Lowering Ticagrelor Maintenance Dose Early After Myocardial Infarction on Platelet Inhibition (ELECTRA Pilot Study).
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Collegium Medicum w Bydgoszczy · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The ELECTRA pilot study is a randomized, open-label, pharmacokinetic and pharmacodynamic trial designed to evaluate the effect of ticagrelor maintenance dose reduction on platelet inhibition in stable patients who recently underwent acute myocardial infarction and were treated with percutaneous coronary intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ticagrelor 90 mg | Ticagrelor 90 mg twice daily |
| DRUG | Ticagrelor 60 mg | Ticagrelor 60 mg daily |
Timeline
- Start date
- 2017-08-11
- Primary completion
- 2018-02-23
- Completion
- 2018-02-23
- First posted
- 2017-08-16
- Last updated
- 2023-04-21
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT03251859. Inclusion in this directory is not an endorsement.